newsGP - Second SGLT2 inhibitor approved for heart failure - RACGP
Empagliflozin has been added to the PBS for symptomatic heart failure with reduced ejection fraction, regardless of diabetes status.
News
Empagliflozin has been added to the PBS for symptomatic heart failure with reduced ejection fraction, regardless of diabetes status.
The EMPEROR-Reduced trial found empagliflozin, in addition … [+3433 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
